The fragment-approach: An update

Teague, 1999, The design of leadlike combinatorial libraries, Angew. Chem. Int. Ed., 38, 3743, 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U Hann, 2004, Pursuing the leadlikeness concept in pharmaceutical research, Curr. Opin. Chem. Biol., 8, 255, 10.1016/j.cbpa.2004.04.003 Leach, 2006, Fragment screening: an introduction, Mol. BioSys., 2, 429, 10.1039/b610069b Fattori, 2004, Molecular recognition: the fragment approach in lead generation, Drug Discov. Today, 9, 229, 10.1016/S1359-6446(03)03007-1 Orry, 2006, Structure-based development of target-specific compound libraries, Drug Discov. Today, 11, 261, 10.1016/S1359-6446(05)03717-7 Wood, 2005, Substrate activity screening: a fragment-based method for the rapid identification of nonpeptidic protease inhibitors, J. Am. Chem. Soc., 127, 15521, 10.1021/ja0547230 Hajduk, 1997, Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR, J. Am. Chem. Soc., 119, 5818, 10.1021/ja9702778 Hajduk, 1999, High-throughput nuclear magnetic resonance-based screening, J. Med. Chem., 42, 2315, 10.1021/jm9901475 Feliz, 2006, Fast 2D NMR ligand screening using Hadamard spectroscopy, J. Am. Chem. Soc., 128, 7146, 10.1021/ja0608949 Dalvit, 2005, Sensitivity improvement in 19F-based screening experiments: theoretical considerations and experimental applications, J. Am. Chem. Soc., 127, 13380, 10.1021/ja0542385 Vanwetswinkel, 2005, TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery, Chem. Biol., 12, 207, 10.1016/j.chembiol.2004.12.004 Nienaber, 2000, Discovering novel ligands for macromolecules using X-ray crystallographic screening, Nat. Biotechnol., 18, 1105, 10.1038/80319 Mooij, 2006, Automated protein-ligand crystallography for structure-based drug design, ChemMedChem, 1, 827, 10.1002/cmdc.200600074 Hartshorn, 2005, Fragment-based lead discovery using x-ray crystallography, J. Med. Chem., 48, 403, 10.1021/jm0495778 Howard, 2006, Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors, J. Med. Chem., 39, 1346, 10.1021/jm050850v Metz, 2004, Small molecule screening on chemical microarrays, 213 Neumann, 2005, Discovery of thrombin inhibitor fragments from chemical microarray screening, Lett. Drug Discov., 2, 563, 10.2174/157018005774717343 Slon-Usakiewicz, 2005, Frontal affinity chromatography with MS detection (FAC-MS) in drug discovery, Drug Discov. Today, 10, 409, 10.1016/S1359-6446(04)03360-4 Seth, 2005, SAR by MS: Discovery of a new class of RNA-binding small molecules for the Hepatitis C virus: internal ribosome entry site IIA subdomain, J. Med. Chem., 48, 7099, 10.1021/jm050815o Buck, 2005, Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor, Proc. Natl. Acad. Sci. U S A, 102, 2719, 10.1073/pnas.0500016102 Scheer, 2006, A common allosteric site and mechanism in caspases, Proc. Natl. Acad. Sci. U S A, 103, 7595, 10.1073/pnas.0602571103 Klein, 1999, Detecting binding affinity to immobilized receptor proteins in compound libraries by HR-MAS STD NM, J. Am. Chem. Soc., 121, 5336, 10.1021/ja990706x Marquardsen, 2006, Development of a dual cell, flow-injection sample holder, and NMR probe for comparative ligand-binding studies, J. Magn. Reson., 182, 55, 10.1016/j.jmr.2006.05.018 Wyss, 2004, Non-peptidic small-molecule inhibitors of the single-chain hepatitis C virus NS3 protease/NS4A cofactor complex discovered by structure-based NMR screening, J. Med. Chem., 47, 2486, 10.1021/jm0305117 Liu, 2003, Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor, J. Med. Chem., 46, 4232, 10.1021/jm034122o Hajduk, 1997, One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules, J. Am. Chem. Soc., 119, 12257, 10.1021/ja9715962 Meyer, 1999, Characterization of ligand binding by saturation transfer difference NMR spectroscopy, Angew. Chem. Int. Ed., 38, 1784, 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q Dalvit, 2003, Fluorine-NMR experiments for high-throughput screening: theoretical aspects, practical considerations, and range of applicability, J. Am. Chem. Soc., 125, 7696, 10.1021/ja034646d Dalvit, 2004, Reliable high-throughput functional screening with 3-FABS, Drug Discov. Today, 9, 595, 10.1016/S1359-6446(04)03161-7 Jahnke, 2002, NMR reporter screening for the detection of high-affinity ligands, Angew. Chem. Int. Ed., 41, 3420, 10.1002/1521-3773(20020916)41:18<3420::AID-ANIE3420>3.0.CO;2-E Schade, 2005, NMR fragment screening: tackling protein-protein interaction targets, Curr. Opin. Drug Discov. Dev., 8, 365 Davies, 2006, Pyramid: an integrated space platform for fragment-based drug discovery, 193 Blaney, 2006, Fragment-based lead discovery and optimization using x-ray crystallography, computational chemistry, and highthroughput organic synthesis, 215 Cooper, 2002, Optical biosensors in drug discovery, Nat. Rev. Drug Discov., 1, 515, 10.1038/nrd838 Hofstadler, 2006, Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes, Nat. Rev. Drug Discov., 5, 585, 10.1038/nrd2083 Oslob, 2004, Tethering in early target assessment, Drug Discov. Today: Targets, 143, 10.1016/S1741-8372(04)02441-7